Literature DB >> 30283992

Seeking to introduce a pharmacoeconomics framework in Cyprus.

Panagiotis Petrou1.   

Abstract

Year:  2018        PMID： 30283992     DOI： 10.1007/s00038-018-1161-z

Source DB:  PubMed          Journal:  Int J Public Health        ISSN： 1661-8556            Impact factor:   3.380


× No keyword cloud information.
  7 in total

1.  Explaining drug spending trends: does perception match reality?

Authors:  R W Dubois; A J Chawla; C A Neslusan; M W Smith; S Wade
Journal:  Health Aff (Millwood)       Date:  2000 Mar-Apr       Impact factor: 6.301

2.  Contribution of pharmaceutical innovation to longevity growth in Germany and France, 2001-7.

Authors:  Frank R Lichtenberg
Journal:  Pharmacoeconomics       Date:  2012-03       Impact factor: 4.981

3.  Cancer drugs in the United States: Justum Pretium--the just price.

Authors:  Hagop M Kantarjian; Tito Fojo; Michael Mathisen; Leonard A Zwelling
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

4.  A Framework for Applying Health Technology Assessment in Cyprus: Thoughts, Success Stories, and Recommendations.

Authors:  Panagiotis Petrou; Michalis A Talias
Journal:  Value Health Reg Issues       Date:  2013-09-13

5.  Evidence synthesis for decision making 1: introduction.

Authors:  Sofia Dias; Nicky J Welton; Alex J Sutton; A E Ades
Journal:  Med Decis Making       Date:  2013-07       Impact factor: 2.583

6.  A pilot study to assess feasibility of value based pricing in Cyprus through pharmacoeconomic modelling and assessment of its operational framework: sorafenib for second line renal cell cancer.

Authors:  Panagiotis Petrou; Michael A Talias
Journal:  Cost Eff Resour Alloc       Date:  2014-05-03

Review 7.  Feasibility and attractiveness of indication value-based pricing in key EU countries.

Authors:  Mathias Flume; Marc Bardou; Stefano Capri; Oriol Sola-Morales; David Cunningham; Lars-Ake Levin; Nicolas Touchot
Journal:  J Mark Access Health Policy       Date:  2016-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.